Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus

被引:107
作者
Riemenschneider, J
Garrison, A
Geisbert, J
Jahrling, P
Hevey, M
Negley, D
Schmaljohn, A
Lee, J
Hart, MK
Vanderzanden, L
Custer, D
Bray, M
Ruff, A
Ivins, B
Bassett, A
Rossi, C
Schmaljohn, C [1 ]
机构
[1] USA, Med Res Inst Infect Dis, Div Virol, Frederick, MD 21702 USA
[2] USA, Med Res Inst Infect Dis, Bacteriol Div, Frederick, MD 21702 USA
[3] USA, Med Res Inst Infect Dis, Diagnost Syst Div, Frederick, MD 21702 USA
关键词
Bacillus anthracis; VEEV; EBOV and MARV; DNA vaccines;
D O I
10.1016/S0264-410X(03)00362-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Multiagent DNA vaccines for highly pathogenic organisms offer an attractive approach for preventing naturally occurring or deliberately introduced diseases. Few animal studies have compared the feasibility of combining unrelated gene vaccines. Here, we demonstrate that DNA vaccines to four dissimilar pathogens that are known biowarfare agents, Bacillus anthracis, Ebola (EBOV), Marburg (MARV), and Venezuelan equine encephalitis virus (VEEV), can elicit protective immunity in relevant animal models. In addition, a combination of all four vaccines is shown to be equally as effective as the individual vaccines for eliciting immune responses in a single animal species. These results demonstrate for the first time the potential of combined DNA vaccines for these agents and point to a possible method of rapid development of multiagent vaccines for disparate pathogens Such as those that might be encountered in a biological attack. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4071 / 4080
页数:10
相关论文
共 52 条
[21]   CLONING AND EXPRESSION OF THE BACILLUS-ANTHRACIS PROTECTIVE ANTIGEN GENE IN BACILLUS-SUBTILIS [J].
IVINS, BE ;
WELKOS, SL .
INFECTION AND IMMUNITY, 1986, 54 (02) :537-542
[22]   EFFICACY OF A STANDARD HUMAN ANTHRAX VACCINE AGAINST BACILLUS-ANTHRACIS SPORE CHALLENGE IN GUINEA-PIGS [J].
IVINS, BE ;
FELLOWS, PF ;
NELSON, GO .
VACCINE, 1994, 12 (10) :872-874
[23]   PROTECTIVE EFFICACIES OF LIVE ATTENUATED AND FORMALDEHYDE-INACTIVATED VENEZUELAN EQUINE ENCEPHALITIS-VIRUS VACCINES AGAINST AEROSOL CHALLENGE IN HAMSTERS [J].
JAHRLING, PB ;
STEPHENSON, EH .
JOURNAL OF CLINICAL MICROBIOLOGY, 1984, 19 (03) :429-431
[24]  
Johnson ED, 1996, ARCH VIROL, P101
[25]  
LILJESTROM P, 1991, J VIROL, V65, P147
[26]   Passive protection by polyclonal antibodies against Bacillus anthracis infection in guinea pigs [J].
Little, SF ;
Ivins, BE ;
Fellows, PF ;
Friedlander, AM .
INFECTION AND IMMUNITY, 1997, 65 (12) :5171-5175
[27]  
MATHEWS JH, 1982, J IMMUNOL, V129, P2763
[28]   ROLE OF COMPLEMENT AND THE FC PORTION OF IMMUNOGLOBULIN-G IN IMMUNITY TO VENEZUELAN EQUINE ENCEPHALOMYELITIS VIRUS-INFECTION WITH GLYCOPROTEIN-SPECIFIC MONOCLONAL-ANTIBODIES [J].
MATHEWS, JH ;
ROEHRIG, JT ;
TRENT, DW .
JOURNAL OF VIROLOGY, 1985, 55 (03) :594-600
[29]   Comparison of the protective efficacy of DNA and baculovirus-derived protein vaccines for EBOLA virus in guinea pigs [J].
Mellquist-Riemenschneider, JL ;
Garrison, AR ;
Geisbert, JB ;
Saikh, KU ;
Heidebrink, KD ;
Jahrling, PB ;
Ulrich, RG ;
Schmaljohn, CS .
VIRUS RESEARCH, 2003, 92 (02) :187-193
[30]   EVIDENCE FOR PLASMID-MEDIATED TOXIN PRODUCTION IN BACILLUS-ANTHRACIS [J].
MIKESELL, P ;
IVINS, BE ;
RISTROPH, JD ;
DREIER, TM .
INFECTION AND IMMUNITY, 1983, 39 (01) :371-376